Clinical Trials Directory

Trials / Completed

CompletedNCT04912622

RPE Characterisation With Transscleral Optical Phase Imaging in Retinal Disorders

Cross Sectional Study: in Vivo Morphometric Characterisation of Human Retinal Pigment Epithelium With Transscleral Optical Phase Imaging in Photoreceptor/ Retinal Pigment Epithelium/ Bruch's Membrane/ Choriocapillaris Complex Disorders

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
210 (actual)
Sponsor
Luzerner Kantonsspital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Accumulating evidence suggest that the functional unit of photoreceptor/ retinal pigment epithelium (RPE)/Bruch's membrane/choriocapillaris plays a key role in pathophysiologic processes of a wide range of medical retinal disorders of the eye. Little is known about in vivo morphometric characteristics of human RPE cells as in vivo observation of these cells was so far technically challenging and hence nearly impossible to implement in a clinical setting. Transscleral optical phase imaging is a novel in-vivo microscopy technique allowing human RPE imaging on a cellular level with the potential of clinical application in a multimodal retinal imaging approach for diagnostic purpose in medical retina patients.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTClinical TrialRetinal image acquisition with Cellularis version 2.0

Timeline

Start date
2021-05-19
Primary completion
2022-10-31
Completion
2022-10-31
First posted
2021-06-03
Last updated
2023-03-07

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04912622. Inclusion in this directory is not an endorsement.

RPE Characterisation With Transscleral Optical Phase Imaging in Retinal Disorders (NCT04912622) · Clinical Trials Directory